miRNA profiling in vitreous humor, vitreal exosomes and serum from uveal melanoma patients: Pathological and diagnostic implications

References

• Materin MA, Faries M, Kluger HM. Molecular alternations in uveal melanoma. Curr Probl Cancer 2011; 35(4):211-24; PMID:21911184; http://dx.doi.org/10.1016/j.currproblcancer.2011.07.004
   PubMed Web of Science ®Google Scholar
• McLaughlin CC, Wu XC, Jemal A, Martin HJ, Roche LM, Chen VW. Incidence of noncutaneous melanomas in the U.S. 2005; Cancer. 103:1000-7; PMID:15651058
   PubMed Web of Science ®Google Scholar
• Dithmar S, Diaz CE, Grossniklaus HE. Intraocular melanoma spread to regional lymph nodes: report of two cases. Retina 2000; 20:76-9; PMID:10696752; http://dx.doi.org/10.1097/00006982-200001000-00014
   PubMed Web of Science ®Google Scholar
• Kujala E1, Mäkitie T, Kivelä T. Very long-term prognosis of patients with malignant uveal melanoma. Invest Ophthalmol Vis Sci 2003; 44(11):4651-9; PMID:14578381; http://dx.doi.org/10.1167/iovs.03-0538
   PubMed Web of Science ®Google Scholar
• Singh AD, Topham A. Survival rates with uveal melanoma in the United States:1973-1997. Ophthalmology 2003; 110(5):962-5; PMID:12750098; http://dx.doi.org/10.1016/S0161-6420(03)00077-0
   PubMed Web of Science ®Google Scholar
• Yang W, Hu S, Wang J, Wang L, Zheng B. Color Doppler imaging diagnosis of intra-ocular tumor. Chin Med J (Engl) 1997; 110(9):664-6; PMID:9642319
   PubMed Web of Science ®Google Scholar
• Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K, Guo J, Zhang Y, Chen J, Guo X, et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 2008; 18(10):997-1006; PMID:18766170; http://dx.doi.org/10.1038/cr.2008.282
   PubMed Web of Science ®Google Scholar
• Gilad S, Meiri E, Yogev Y, Benjamin S, Lebanony D, Yerushalmi N, Benjamin H, Kushnir M, Cholakh H, Melamed N, et al. Serum microRNAs are promising novel biomarkers. PLoS One 2008; 3(9):e3148; PMID:18773077; http://dx.doi.org/10.1371/journal.pone.0003148
   PubMed Web of Science ®Google Scholar
• Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant KC, Allen A, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 2008; 105(30):10513-8; PMID:18663219; http://dx.doi.org/10.1073/pnas.0804549105
   PubMed Web of Science ®Google Scholar
• Kosaka N, Iguchi H, Ochiya T. Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis. Cancer Sci 2010; 101(10):2087-92; PMID:20624164; http://dx.doi.org/10.1111/j.1349-7006.2010.01650.x
   PubMed Web of Science ®Google Scholar
• Valadi H, Ekström K, Bossios A, Sjöstrand M, Lee JJ, Lötvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 2007; 9(6):654-9; PMID:17486113; http://dx.doi.org/10.1038/ncb1596
   PubMed Web of Science ®Google Scholar
• Corrado C, Raimondo S, Chiesi A, Ciccia F, De Leo G, Alessandro R. Exosomes as intercellular signaling organelles involved in health and disease: basic science and clinical applications. Int J Mol Sci 2013; 14(3):5338-66; PMID:23466882; http://dx.doi.org/10.3390/ijms14035338
   PubMed Web of Science ®Google Scholar
• Hendrix A, Westbroek W, Bracke M, De Wever O. An ex(o)citing machinery for invasive tumor growth. Cancer Res 2010; 70(23):9533-7; PMID:21098711; http://dx.doi.org/10.1158/0008-5472.CAN-10-3248
   PubMed Web of Science ®Google Scholar
• Ragusa M, Caltabiano R, Russo A, Puzzo L, Avitabile T, Longo A, Toro MD, Di Pietro C, Purrello M, Reibaldi M. MicroRNAs in vitreus humor from patients with ocular diseases. Mol Vis 2013; 19:430-40; PMID:23441115
   PubMed Web of Science ®Google Scholar
• Blondal T, Jensby Nielsen S, Baker A, Andreasen D, Mouritzen P, Wrang Teilum M, Dahlsveen IK. Assessing sample and miRNA profile quality in serum and plasma or other biofluids. Methods 2013; 59(1):S1-6; PMID:23036329; http://dx.doi.org/10.1016/j.ymeth.2012.09.015
   PubMed Web of Science ®Google Scholar
• Pacifici M, Delbue S, Kadri F, Peruzzi F. Cerebrospinal fluid MicroRNA profiling using quantitative real time PCR. J Vis Exp 2014; (83):e51172; PMID:24514260
   Google Scholar
• Kosaka N, Yoshioka Y, Hagiwara K, Tominaga N, Katsuda T, Ochiya T. Trash or Treasure: extracellular microRNAs and cell-to-cell communication. Front Genet 2013; 4:173; PMID:24046777; http://dx.doi.org/10.3389/fgene.2013.00173
   PubMedGoogle Scholar
• Shah MY, Calin GA. The mix of two worlds: non-coding RNAs and hormones. Nucleic Acid Ther 2013; 23(1):2-8; PMID:23051203
   PubMed Web of Science ®Google Scholar
• Boon RA, Vickers KC. Intercellular transport of microRNAs. Arterioscler Thromb Vasc Biol 2013; 33(2):186-92; PMID:23325475; http://dx.doi.org/10.1161/ATVBAHA.112.300139
   PubMed Web of Science ®Google Scholar
• Turchinovich A, Weiz L, Langheinz A, Burwinkel B. Characterization of extracellular circulating microRNA. Nucleic Acids Res 2011; 39(16):7223-33; PMID:21609964; http://dx.doi.org/10.1093/nar/gkr254
   PubMed Web of Science ®Google Scholar
• Vickers KC, Remaley AT. Lipid-based carriers of microRNAs and intercellular communication. Curr Opin Lipidol 2012; 23(2):91-7; PMID:22418571; http://dx.doi.org/10.1097/MOL.0b013e328350a425
   PubMed Web of Science ®Google Scholar
• Di Leva G, Croce CM. miRNA profiling of cancer. Curr Opin Genet Dev 2013 23(1):3-11; PMID:23465882; http://dx.doi.org/10.1016/j.gde.2013.01.004
   PubMed Web of Science ®Google Scholar
• Fortunato O, Boeri M, Verri C, Conte D, Mensah M, Suatoni P, Pastorino U, Sozzi G. Assessment of circulating microRNAs in plasma of lung cancer patients. Molecules 2014; 19(3):3038-54; PMID:24619302; http://dx.doi.org/10.3390/molecules19033038
   PubMed Web of Science ®Google Scholar
• Ganepola GA, Rutledge JR, Suman P, Yiengpruksawan A, Chang DH. Novel blood-based microRNA biomarker panel for early diagnosis of pancreatic cancer. World J Gastrointest Oncol 2014; 6(1):22-33; PMID:24578785; http://dx.doi.org/10.4251/wjgo.v6.i1.22
   PubMed Web of Science ®Google Scholar
• Mar-Aguilar F, Rodríguez-Padilla C, Reséndez-Pérez D. Use of serum-circulating miRNA profiling for the identification of breast cancer biomarkers. Methods Mol Biol 2014; 1165:71-80; PMID:24839019; http://dx.doi.org/10.1007/978-1-4939-0856-1_6
   PubMedGoogle Scholar
• Wang J, Huang SK, Zhao M, Yang M, Zhong JL, Gu YY, Peng H, Che YQ, Huang CZ. Identification of a circulating microRNA signature for colorectal cancer detection. PLoS One 2014; 9(4):e87451; PMID:24709885; http://dx.doi.org/10.1371/journal.pone.0087451
   PubMedGoogle Scholar
• Ando H, Niki Y, Ito M, Akiyama K, Matsui MS, Yarosh DB, Ichihashi M. Melanosomes are transferred from melanocytes to keratinocytes through the processes of packaging, release, uptake, and dispersion. J Invest Dermatol 2012; 132(4):1222-9; PMID:22189785; http://dx.doi.org/10.1038/jid.2011.413
   PubMed Web of Science ®Google Scholar
• Crescitelli R, Lässer C, Szabó TG, Kittel A, Eldh M, Dianzani I, Buzás EI, Lötvall J. Distinct RNA profiles in subpopulations of extracellular vesicles: apoptotic bodies, microvesicles and exosomes. J Extracell Vesicles 2013; 12:2; PMID:24223256
   PubMedGoogle Scholar
• Kalra H, Simpson RJ, Ji H, Aikawa E, Altevogt P, Askenase P, Bond VC, Borràs FE, Breakefield X, Budnik V, et al. Vesiclepedia: a compendium for extracellular vesicles with continuous community annotation. PLoS Biol 2012; 10(12):e1001450; PMID:23271954; http://dx.doi.org/10.1371/journal.pbio.1001450
   PubMed Web of Science ®Google Scholar
• Filipazzi P, Bürdek M, Villa A, Rivoltini L, Huber V. Recent advances on the role of tumor exosomes in immunosuppression and disease progression. Semin Cancer Biol 2012; 22(4):342-9; PMID:22369922; http://dx.doi.org/10.1016/j.semcancer.2012.02.005
   PubMed Web of Science ®Google Scholar
• Yang C, Robbins PD. The roles of tumor-derived exosomes in cancer pathogenesis. Clin Dev Immunol 2011; 2011:842849; PMID:22190973
   PubMed Web of Science ®Google Scholar
• Xiao D, Ohlendorf J, Chen Y, Taylor DD, Rai SN, Waigel S, Zacharias W, Hao H, McMasters KM. Identifying mRNA, microRNA and protein profiles of melanoma exosomes. PLoS One 2012; 7(10):e46874; PMID:23056502; http://dx.doi.org/10.1371/journal.pone.0046874
   PubMed Web of Science ®Google Scholar
• Gaudi S, Messina JL. Molecular bases of cutaneous and uveal melanomas. Patholog Res Int 2011; 2011:159421; PMID:21876842
   PubMedGoogle Scholar
• Achberger S, Aldrich W, Tubbs R, Crabb JW, Singh AD, Triozzi PL. Circulating immune cell and microRNA in patients with uveal melanoma developing metastatic disease. Mol Immunol 2014; 58(2):182-6; PMID:24370793; http://dx.doi.org/10.1016/j.molimm.2013.11.018
   PubMed Web of Science ®Google Scholar
• Boldin MP, Taganov KD, Rao DS, Yang L, Zhao JL, Kalwani M, Garcia-Flores Y, Luong M, Devrekanli A, Xu J, et al. MiR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice. J Exp Med 2011; 208(6):1189-201; PMID:21555486; http://dx.doi.org/10.1084/jem.20101823
   PubMed Web of Science ®Google Scholar
• Paik JH, Jang JY, Jeon YK, Kim WY, Kim TM, Heo DS, Kim CW. MicroRNA-146a downregulates NFκB activity via targeting TRAF6 and functions as a tumor suppressor having strong prognostic implications in NK/T cell lymphoma. Clin Cancer Res 2011; 17(14):4761-71; PMID:21610143; http://dx.doi.org/10.1158/1078-0432.CCR-11-0494
   PubMed Web of Science ®Google Scholar
• Sheedy FJ, O'Neill LA. Adding fuel to fire: microRNAs as a new class of mediators of inflammation. Ann Rheum Dis 2008; 67 3:iii50-5; PMID:19022814
   PubMed Web of Science ®Google Scholar
• Mastropasqua R, Toto L, Cipollone F, Santovito D, Carpineto P, Mastropasqua L. Role of microRNAs in the modulation of diabetic retinopathy. Prog Retin Eye Res 2014; 43C:92-107; PMID:25128741; http://dx.doi.org/10.1016/j.preteyeres.2014.07.003
   PubMed Web of Science ®Google Scholar
• Forloni M, Dogra SK, Dong Y, Conte D Jr, Ou J, Zhu LJ, Deng A, Mahalingam M, Green MR, Wajapeyee N. miR-146a promotes the initiation and progression of melanoma by activating Notch signaling. Elife 2014; 3:e01460; PMID:24550252; http://dx.doi.org/10.7554/eLife.01460
   PubMedGoogle Scholar
• Onken MD, Worley LA, Long MD, Duan S, Council ML, Bowcock AM, Harbour JW. Oncogenic mutations in GNAQ occur early in uveal melanoma. Invest Ophthalmol Vis Sci 2008; 49(12):5230-4; PMID:18719078; http://dx.doi.org/10.1167/iovs.08-2145
   PubMed Web of Science ®Google Scholar
• Chen X, Wang J, Shen H, Lu J, Li C, Hu DN, Dong XD, Yan D, Tu L. Epigenetics, microRNAs, and carcinogenesis: functional role of microRNA-137 in uveal melanoma. Invest Ophthalmol Vis Sci 2011; 52(3):1193-9; PMID:21051724; http://dx.doi.org/10.1167/iovs.10-5272
   PubMed Web of Science ®Google Scholar
• Ozsolak F, Poling LL, Wang Z, Liu H, Liu XS, Roeder RG, Zhang X, Song JS, Fisher DE. Chromatin structure analyses identify miRNA promoters. Genes Dev 2008; 22(22):3172-83; PMID:19056895; http://dx.doi.org/10.1101/gad.1706508
   PubMed Web of Science ®Google Scholar
• Yajima I, Kumasaka MY, Thang ND, Goto Y, Takeda K, Iida M, Ohgami N, Tamura H, Yamanoshita O, Kawamoto Y, et al. Molecular Network Associated with MITF in Skin Melanoma Development and Progression. J Skin Cancer 2011; 2011:730170; PMID:22046555; http://dx.doi.org/10.1155/2011/730170
   PubMedGoogle Scholar
• Field MG, Harbour JW. Recent developments in prognostic and predictive testing in uveal melanoma. Curr Opin Ophthalmol 2014; 25(3):234-9; PMID:24713608; http://dx.doi.org/10.1097/ICU.0000000000000051
   PubMed Web of Science ®Google Scholar
• Rashid AB, Grossniklaus HE. Clinical, pathologic, and imaging features and biological markers of uveal melanoma. Methods Mol Biol 2014; 1102:397-425; PMID:24258990; http://dx.doi.org/10.1007/978-1-62703-727-3_21
   PubMedGoogle Scholar
• Simó-Servat O, Hernández C, Simó R. Usefulness of the vitreous fluid analysis in the translational research of diabetic retinopathy. Mediators Inflamm 2012; 2012:872978
   PubMed Web of Science ®Google Scholar
• Damato B, Lecuona K. Conservation of eyes with choroidal melanoma by a multimodality approach to treatment: an audit of 1632 patients. Ophthalmology 2004; 111(5):977-83; PMID:15121377; http://dx.doi.org/10.1016/j.ophtha.2003.09.028
   PubMed Web of Science ®Google Scholar
• Ragusa M, Statello L, Maugeri M, Barbagallo C, Passanisi R, Alhamdani MS, Li Destri G, Cappellani A, Barbagallo D, Scalia M, et al. Highly skewed distribution of miRNAs and proteins between colorectal cancer cells and their exosomes following Cetuximab treatment: biomolecular, genetic and translational implications. Oncoscience 2014; 1(2):132-157; PMID:25594007
   PubMedGoogle Scholar